Sign In
Buy CABA
$3.58
-0.100 (-2.72%)
At Close: Jun 03, 2026
Cabaletta Bio, Inc. (CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, and Ar
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief Medical Officer
12:00am, Thursday, 02'nd Jul 2020
Rexgenero, a regenerative medicine company appoints Dr Gilbert Wagener as Senior Vice President and Chief Medical Officer.
Hedge Funds Keep Buying Cabaletta Bio, Inc. (CABA)
08:25pm, Wednesday, 24'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Global CAR T Cell Therapy Market to 2026 - by Regions, Targeted Antigens, Clinical Trials/Study & Companies - ResearchAndMarkets.com
12:00am, Wednesday, 24'th Jun 2020
The
Horse racing tips TODAY: Who to back at Beverley, Chepstow and Kempton
04:30am, Tuesday, 23'rd Jun 2020
Horse racing tips for June 23 - who to back at Beverley, Chepstow and Kempton.
Cabaletta Bio (NASDAQ:CABA) Trading Up 17.2%
02:22am, Sunday, 21'st Jun 2020
Cabaletta Bio (NASDAQ:CABA)’s stock price rose 17.2% during trading on Friday . The company traded as high as $8.72 and last traded at $8.57, approximately 97,862 shares changed hands during mid-day
Royal Ascot tips for Tuesday
07:00am, Tuesday, 16'th Jun 2020
Horse racing tips for the seven races on day one of Royal Ascot
Royal Ascot 2020 tips: Newsboy’s 1-2-3 and best bets for day one
06:01am, Tuesday, 16'th Jun 2020
Royal Ascot 2020 takes place behind closed doors this year, over five days from June 16-20. Newsboy has tips for every race at the big meeting in Berkshire
Horse Power: Zaaki can win the Diomed Stakes again
05:00pm, Friday, 12'th Jun 2020
Sir Michael Stoute's five-year-old can score at Newbury, while Peaceful, Foxtrot Lady, Muntadab, Impressor and Redgrave may also win ahead of Royal Ascot
Les valeurs à suivre aujourd'hui à la Bourse de Paris Mercredi 10 juin 2020
07:01am, Wednesday, 10'th Jun 2020Celyad devient Celyad Oncology
12:00am, Wednesday, 10'th Jun 2020
Regulatory News: Celyad SA (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), une société biotechnologique de stade clinique fo
Cabaletta Bio, Inc. (CABA) Moves to Strong Buy: Rationale Behind the Upgrade
04:00pm, Monday, 01'st Jun 2020
Cabaletta Bio, Inc. (CABA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
Cabaletta Bio Announces Expansion of Sponsored Research Agreement with the University of Pennsylvania
12:00pm, Thursday, 28'th May 2020
Cabaletta Bio, Inc. (CABA), a clinical stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today
Cabaletta Bio to Present at Jefferies Virtual Healthcare Conference
12:00pm, Wednesday, 27'th May 2020
PHILADELPHIA, May 27, 2020 -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies.
Cabaletta Bio, Inc. (CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today
